Macrophage Membrane‐Biomimetic Multi‐Layered Nanoparticles Targeting Synovial Angiogenesis for Osteoarthritis Therapy
Authors:
- 14 October 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (2) , e2401985
Abstract
Osteoarthritis (OA) is an inflammatory and progressive joint disease characterized by angiogenesis‐mediated sustained, chronic, and low‐grade synovitis. Anti‐angiogenesis is emerging as a strategy for attenuating OA progression, but is often compromised by poor targeted drug delivery and immune clearance. Recent studies have identified macrophages formed a “protective barrier” in the lining layer (LL) of synovium, which blocked the communication of joint cavity and sublining layer (SL) of synovium. Inspired by natural mimicry, macrophage membrane‐camouflaged drug delivery is explored to avoid immune clearance. Based on the single cell RNA sequencing, the CD34+ synovial cells are identified as “sentinel cells” for synovium angiogenesis. Consequently, CD34 antibody‐modified macrophage membrane is constructed to target new angiogenesis. Hence, a biomimetic multi‐layered nanoparticle (NP) is developed that incorporates axitinib‐loaded poly(lactic‐co‐glycolic) acid (PLGA) with CD34 antibody modified macrophage membrane (Atb@NP@Raw@CD34) to specifically deliver axitinib (Atb) to the SL and sustain inhibiting angiogenesis without immune elimination. It is found that the Atb@NP@Raw@CD34 can pass through macrophage “barrier”, specifically targeting CD34+ cells, continuously releasing Atb and anti‐angiogenesis in OA synovitis. Furthermore, in vivo data demonstrated that Atb@NP@Raw@CD34 can attenuate joint degeneration by inhibiting synovium angiogenesis‐mediated synovitis. In conclusion, local injection of Atb@NP@Raw@CD34 presents a promising approach for clinically impeding OA progression.Keywords
Funding Information
- National Natural Science Foundation of China (#82372460, #U22A20284)
- Natural Science Foundation of Chongqing Municipality (CSTB2022NSCQ‐MSX0814)
- China Postdoctoral Science Foundation (2022M720605)
This publication has 69 references indexed in Scilit:
- Biomimetic Porous Ti6Al4V Implants: A Novel Interbody Fusion Cage via Gel‐Casting Technique to Promote Spine FusionAdvanced Healthcare Materials, 2024
- Chondrocyte‐Targeted Delivery System of Sortase A‐Engineered Extracellular Vesicles Silencing MMP13 for Osteoarthritis TherapyAdvanced Healthcare Materials, 2024
- Intra‐Articular Injectable Biomaterials for Cartilage Repair and RegenerationAdvanced Healthcare Materials, 2024
- Injectable Bioactive Antioxidative One‐Component Polycitrate Hydrogel with Anti‐Inflammatory Effects for Osteoarthritis Alleviation and Cartilage ProtectionAdvanced Healthcare Materials, 2023
- Reprogramming Mitochondrial Metabolism in Synovial Macrophages of Early Osteoarthritis by a Camouflaged Meta‐DefensomeAdvanced Materials, 2022
- Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee OsteoarthritisJAMA, 2021
- Macrophage‐Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic StrokeAdvanced Science, 2021
- Stem Cell‐Recruiting Injectable Microgels for Repairing OsteoarthritisAdvanced Functional Materials, 2021
- Diagnosis and Treatment of Hip and Knee OsteoarthritisJAMA, 2021
- Cell Membrane Coating NanotechnologyAdvanced Materials, 2018